On this page
B9D2
B9 domain containing 2
B9D2 is located on the long (q) arm of chromosome 19, at band 19q13.2. Arm ratio per GRCh38 - banding schematic.
Explore chromosome 19 in the library →Available at Jeen Health
Clinical tests that include this
Overview
B9D2 is located on chromosome 19 and encodes a 175-amino-acid protein that forms part of the ciliary transition zone complex. Cilia are microscopic, antenna-like structures extending from the surface of most human cells, where they detect chemical signals, sense fluid flow, and coordinate developmental programmes during embryonic growth.
The transition zone acts as a selective barrier controlling which molecules enter and exit the cilium, ensuring proper composition and function of this organelle. B9D2 works alongside other transition zone proteins to maintain this barrier and support ciliary structure. Autosomal recessive inheritance means both gene copies must harbour pathogenic variants for disease to manifest, making carrier screening relevant for family planning decisions in at-risk populations.
What the gene does
The B9D2 protein localises to the transition zone, a cylindrical gate-keeping structure positioned where the cilium emerges from the cell body. This region comprises protein complexes that anchor the ciliary membrane to the underlying axoneme (the cilium's internal scaffold) and regulate the passage of proteins and lipids into the ciliary compartment.
B9D2 contributes to the structural integrity of these complexes, helping to form molecular tethers that connect membrane and cytoskeletal components. By participating in transition zone assembly, the protein indirectly influences ciliary signalling pathways including Sonic hedgehog, Wnt, and planar cell polarity cascades that pattern developing tissues. Proper transition zone function is particularly critical during embryogenesis, when ciliary signalling orchestrates organ formation in the brain, kidneys, eyes, skeleton, and other systems. Loss of B9D2 function disrupts this quality-control checkpoint, allowing inappropriate proteins to accumulate in cilia whilst excluding necessary components, ultimately impairing signal transduction and ciliary motility.
Video: Genetics 101
Chromosome location
B9D2 resides at chromosomal band 19q13.2 on the long arm of chromosome 19. The gene spans a relatively compact genomic region and encodes a short transcript that produces a single major protein isoform. This chromosomal location sits within a gene-dense area containing numerous other coding sequences.
Protein structure
The B9D2 protein is organised around a C2 B9-type domain spanning amino acids 2 to 118, which comprises the majority of the 175-residue polypeptide. This domain represents a conserved structural module found across B9 family proteins and is essential for protein-protein interactions within the transition zone complex. The C2 B9-type fold enables B9D2 to bind partner proteins and integrate into the larger transition zone architecture, facilitating its role in ciliary gate formation and membrane organisation.
Key variants
Pathogenic variants in B9D2 are typically loss-of-function changes such as frameshift insertions, deletions, nonsense mutations, or splice-site alterations that prevent production of functional protein. Because the gene is short and the critical B9-type domain occupies most of its length, many missense substitutions within this region can also disrupt protein folding or interaction surfaces. Carriers possess one functional copy and typically show no symptoms, whilst individuals inheriting pathogenic variants from both parents develop ciliopathy phenotypes of varying severity.
Sample of pathogenic variants
5 pathogenic / likely-pathogenic variants from ClinVar, ranked by review status (expert-panel-reviewed first). This is a sample; recurrent founder variants in a specific population may not appear here - see the full ClinVar listing via the link above.
| Variant (HGVS) | Protein change | Classification | Evidence | Associated condition |
|---|---|---|---|---|
c.156_163del | p.Asp53fs | Pathogenic/Likely pathogenic | ★★☆☆ | Joubert syndrome |
c.220C>T | p.Pro74Ser | Pathogenic/Likely pathogenic | ★★☆☆ | Joubert syndrome and related disorders |
c.463G>A | p.Gly155Ser | Pathogenic/Likely pathogenic | ★★☆☆ | Joubert syndrome and related disorders |
c.107T>C | p.Leu36Pro | Pathogenic | ★☆☆☆ | Joubert syndrome |
c.301A>C | p.Ser101Arg | Pathogenic | ★☆☆☆ | Joubert syndrome and related disorders |
Evidence stars indicate ClinVar review status. Individual variant interpretation should always be performed by a qualified clinical laboratory - many variants remain classified as Variants of Uncertain Significance (VUS) pending more research.
Associated conditions
Biallelic B9D2 pathogenic variants cause Meckel-Gruber syndrome, a severe ciliopathy characterised by brain malformations (particularly occipital encephalocele), cystic kidney dysplasia, and polydactyly (extra fingers or toes). This condition is generally incompatible with long-term survival. Some affected individuals present with overlapping features of Joubert syndrome, including distinctive brainstem and cerebellar abnormalities visible on brain imaging, developmental delay, and abnormal eye movements. The clinical spectrum reflects the widespread importance of cilia during foetal development, with variable involvement of the central nervous system, kidneys, liver, eyes, and skeletal system depending on the specific variants and genetic background.
No disease links recorded for this gene in our reference set.
Inheritance pattern
Conditions caused by pathogenic B9D2 variants typically follow autosomal recessive inheritance.
When both parents are carriers, each child has a 25% chance of being affected, 50% of being a carrier, and 25% of being unaffected.
UK clinical status
B9D2 holds green (high-evidence) classification on multiple NHS Genomic Medicine Service gene panels reflecting its established role in ciliopathy diagnosis. It appears on the Fetal Anomalies panel, Intellectual Disability panel, and specialist ciliopathy panels covering neurological, ophthalmological, renal, and rare multisystem presentations. This panel membership indicates strong evidence linking B9D2 variants to these phenotypes and supports its inclusion in clinical genomic testing pathways for affected families and prenatal cases with suggestive ultrasound findings.
Sources: NHS GMS PanelApp · Genomics England PanelApp · NHS National Genomic Test Directory
Frequently asked questions
What does it mean to be a carrier of a B9D2 variant?
Carriers possess one pathogenic B9D2 variant and one functional copy, which provides sufficient protein for normal ciliary function. Carriers do not develop ciliopathy symptoms but can pass the variant to children. If both parents are carriers, each pregnancy has a 25% chance of inheriting both variants and being affected.
How common are B9D2 variants?
Pathogenic B9D2 variants are rare in the general population. Ciliopathies caused by B9D2 mutations occur sporadically in most cases, though certain populations may harbour founder variants at slightly higher frequencies. Carrier screening can identify at-risk couples before pregnancy.
Can B9D2-related conditions be detected before birth?
Some features of Meckel-Gruber syndrome, such as enlarged cystic kidneys, occipital encephalocele, and polydactyly, may be visible on detailed prenatal ultrasound scans performed during the second trimester. Genetic testing can confirm a diagnosis when imaging suggests a ciliopathy, enabling informed decision-making and specialist care planning.